Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP320920.RAtJm0kXWn6oYWncp5a03VhSVI6gL3MLiwkTRKrkocvWg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP320920.RAtJm0kXWn6oYWncp5a03VhSVI6gL3MLiwkTRKrkocvWg130_assertion type Assertion NP320920.RAtJm0kXWn6oYWncp5a03VhSVI6gL3MLiwkTRKrkocvWg130_head.
- NP320920.RAtJm0kXWn6oYWncp5a03VhSVI6gL3MLiwkTRKrkocvWg130_assertion description "[These results not only highlight the potential of a synergistic drug combination of allosteric PARP inhibitors with DNA-damaging agents in genomically unstable cancer cells (regardless of homologous recombination status), but also signify important applications of selective PARP-1 inhibition.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP320920.RAtJm0kXWn6oYWncp5a03VhSVI6gL3MLiwkTRKrkocvWg130_provenance.
- NP320920.RAtJm0kXWn6oYWncp5a03VhSVI6gL3MLiwkTRKrkocvWg130_assertion evidence source_evidence_literature NP320920.RAtJm0kXWn6oYWncp5a03VhSVI6gL3MLiwkTRKrkocvWg130_provenance.
- NP320920.RAtJm0kXWn6oYWncp5a03VhSVI6gL3MLiwkTRKrkocvWg130_assertion SIO_000772 24189460 NP320920.RAtJm0kXWn6oYWncp5a03VhSVI6gL3MLiwkTRKrkocvWg130_provenance.
- NP320920.RAtJm0kXWn6oYWncp5a03VhSVI6gL3MLiwkTRKrkocvWg130_assertion wasDerivedFrom befree-20150227 NP320920.RAtJm0kXWn6oYWncp5a03VhSVI6gL3MLiwkTRKrkocvWg130_provenance.
- NP320920.RAtJm0kXWn6oYWncp5a03VhSVI6gL3MLiwkTRKrkocvWg130_assertion wasGeneratedBy ECO_0000203 NP320920.RAtJm0kXWn6oYWncp5a03VhSVI6gL3MLiwkTRKrkocvWg130_provenance.